Our Team
>
Leadership Team
SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery
Anterior:
School of Medicine researcher awarded $1.25 million dollar grant to study immune response to cancer
Siguiente:
Cancer Research Institute Awards Over $28 Million in Grants to Fuel Immunotherapy Innovations
